Ignite Creation Date:
2025-12-24 @ 12:18 PM
Ignite Modification Date:
2026-02-25 @ 6:59 PM
Study NCT ID:
NCT00478361
Status:
COMPLETED
Last Update Posted:
2020-10-09
First Post:
2007-05-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Distal Urethral Cancer | View |
| None | Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | View |
| None | Proximal Urethral Cancer | View |
| None | Recurrent Bladder Cancer | View |
| None | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | View |
| None | Recurrent Urethral Cancer | View |
| None | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | View |
| None | Stage III Bladder Cancer | View |
| None | Stage IV Bladder Cancer | View |
| None | Transitional Cell Carcinoma of the Bladder | View |
| None | Urethral Cancer Associated With Invasive Bladder Cancer | View |
Keywords: